Skip to content
Subscribe
Follow Us
Subscribe
Follow Us
  • COMPANY
    • About Us
    • Team
  • Science
  • PIPELINE
    • Silvanex Antimicrobial Technology
    • Silvanex for Hospital Wound Care
    • Silvanex for Diabetic Ulcers
    • AND-259 for Breast Cancer
    • AND-254 for Mastectomy Pain
  • News
  • Contact
  • COMPANY
    • About Us
    • Team
  • Science
  • PIPELINE
    • Silvanex Antimicrobial Technology
    • Silvanex for Hospital Wound Care
    • Silvanex for Diabetic Ulcers
    • AND-259 for Breast Cancer
    • AND-254 for Mastectomy Pain
  • News
  • Contact

Andira Recognizes the Outstanding Achievements of Research Scientist Claudia Helena Dietrich, DDS, MSc, PhD

Andira CEO Dana Lambert, PhD says, “I wanted to take the opportunity to recognize Dr. Claudia Dietrich and her outstanding achievements as a research scientist on our team. She is a talented and highly motivated professional and has been a driving force behind the successful development of our wound care

Read More
Andira Pharmaceuticals Inc. is a Vancouver-based biopharmaceutical company focused on the discovery and development of first-in-class cannabinoid therapeutics and medical devices to address unmet needs in infection control, post-surgical recovery, and early-stage breast cancer. Through collaborations with top-ranking academic and clinical partners, Andira aims to translate innovative science into practical healthcare solutions.

Explore

  • Company
  • Science
  • Pipeline
  • News

Contact Us

Investor Relations:

ir@andira.ca

Partnerships:

bd@andira.ca

General inquiries and media:

info@andira.ca

Follow our News & Announcements

Copyright © 2026 Andira Pharmaceuticals
Biotech website design